Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Abstract 5395: CDK12 regulates cellular metabolism to promote therapy resistance in glioblastoma

Jeong-Yeon Mun, Chang Shu, Qiuqiang Gao, Hasan O. Akman, Mike-Andrew Westhoff, Georg Karpel-Massler, Markus D. Siegelin

Cancer Res (2025) 85 (8_Supplement_1): 5395.

https://doi.org/10.1158/1538-7445.AM2025-5395

Published: 21 April 2025

View articletitled, Abstract 5395: CDK12 regulates cellular metabolism to promote therapy resistance in glioblastoma

Journal Articles

Abstract 5385: Concurrent inhibition of the serine/threonine protein kinase AURKB and the fatty acid oxidation enzyme CPT1A demonstrates synthetic lethality in preclinical glioblastoma models

Qiuqiang Gao, Chang Shu, Jeongyeon Mun, Zhe Zhu, Hasan O. Akman, Mike-Andrew Westhoff, Georg Karpel-Massler, Markus D. Siegelin

Cancer Res (2025) 85 (8_Supplement_1): 5385.

https://doi.org/10.1158/1538-7445.AM2025-5385

Published: 21 April 2025

View articletitled, Abstract 5385: Concurrent inhibition of the serine/threonine protein kinase AURKB and the fatty acid oxidation enzyme CPT1A demonstrates synthetic lethality in preclinical glioblastoma models

Journal Articles

Abstract 3070: CDK12 is a novel therapeutic target in glioblastoma

Jeong-Yeon Mun, Chang Shu, Qiuqiang Gao, Mike-Andrew Westhoff, Georg Karpel-Massler, Markus D. Siegelin

Cancer Res (2024) 84 (6_Supplement): 3070.

https://doi.org/10.1158/1538-7445.AM2024-3070

Published: 22 March 2024

View articletitled, Abstract 3070: CDK12 is a novel therapeutic target in glioblastoma

Journal Articles

Abstract LB304: Mechanisms of cell death escape in glioblastoma

Helene von Bandemer, Felix Seyfried, Anne Fleischmann, Georg Karpel-Massler, Aurelia Peraud, Hannah Strobel, Marcin Lyszkiewicz, Klaus Michael Debatin, Mike Andrew Westhoff

Cancer Res (2023) 83 (8_Supplement): LB304.

https://doi.org/10.1158/1538-7445.AM2023-LB304

Published: 14 April 2023

View articletitled, Abstract LB304: Mechanisms of cell death escape in glioblastoma

Journal Articles

MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma

Yiru Zhang, Trang T.T. Nguyen, Enyuan Shang, Angeliki Mela, Nelson Humala, Aayushi Mahajan, Junfei Zhao, Chang Shu, Consuelo Torrini, Maria J. Sanchez-Quintero, Giulio Kleiner, Elena Bianchetti, Mike-Andrew Westhoff, Catarina M. Quinzii, Georg Karpel-Massler, Jeffrey N. Bruce, Peter Canoll, Markus D. Siegelin

Cancer Res (2020) 80 (1): 30–43.

https://doi.org/10.1158/0008-5472.CAN-19-1389

Published: 03 January 2020

View articletitled, MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma

Includes: Supplementary data

Journal Articles

Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic Responses

Georg Karpel-Massler, Chiaki Tsuge Ishida, Elena Bianchetti, Chang Shu, Rolando Perez-Lorenzo, Basil Horst, Matei Banu, Kevin A. Roth, Jeffrey N. Bruce, Peter Canoll, Dario C. Altieri, Markus D. Siegelin

Cancer Res (2017) 77 (13): 3513–3526.

https://doi.org/10.1158/0008-5472.CAN-16-3424

Published: 02 July 2017

View articletitled, Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic Responses

Includes: Supplementary data

Journal Articles

Abstract 2923: A novel cell-penetrating peptide targeting ATF5 (CP-d/n-ATF5) exerts anti-cancer activity in vitro and in vivo against a broad spectrum of human cancers

Georg Karpel-Massler, Chang Shu, Lily Chau, James M. Angelastro, Lloyd A. Greene, Markus D. Siegelin

Cancer Res (2015) 75 (15_Supplement): 2923.

https://doi.org/10.1158/1538-7445.AM2015-2923

Published: 01 August 2015

View articletitled, Abstract 2923: A novel cell-penetrating peptide targeting ATF5 (CP-d/n-ATF5) exerts anti-cancer activity in vitro and in vivo against a broad spectrum of human cancers

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 5395: CDK12 regulates cellular metabolism to promote therapy resistance in glioblastoma

Abstract 5385: Concurrent inhibition of the serine/threonine protein kinase AURKB and the fatty acid oxidation enzyme CPT1A demonstrates synthetic lethality in preclinical glioblastoma models

Abstract 3070: CDK12 is a novel therapeutic target in glioblastoma

Abstract LB304: Mechanisms of cell death escape in glioblastoma

MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma

Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic Responses

Abstract 2923: A novel cell-penetrating peptide targeting ATF5 (CP-d/n-ATF5) exerts anti-cancer activity in vitro and in vivo against a broad spectrum of human cancers

Email alerts

AACR Journals

Update search

Abstract 5395: CDK12 regulates cellular metabolism to promote therapy resistance in glioblastoma

Abstract 5385: Concurrent inhibition of the serine/threonine protein kinase AURKB and the fatty acid oxidation enzyme CPT1A demonstrates synthetic lethality in preclinical glioblastoma models

Abstract 3070: CDK12 is a novel therapeutic target in glioblastoma

Abstract LB304: Mechanisms of cell death escape in glioblastoma

MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma

Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic Responses

Abstract 2923: A novel cell-penetrating peptide targeting ATF5 (CP-d/n-ATF5) exerts anti-cancer activity in vitro and in vivo against a broad spectrum of human cancers

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only